Sanofi buys rest of Merial from Merck for $4 billion

PARIS (Reuters) – French drugmaker Sanofi-Aventis expanded its animal health business by buying the other half of Merial from its U.S. partner Merck for $4 billion in cash while opening the door for a bigger deal.

Leave a Reply